Immunoinformatic Analysis of Calcium-Dependent Protein Kinase 7 (CDPK7) Showed Potential Targets for Toxoplasma

Ali Taghipour1, Sanaz Tavakoli2, Mohamad Sabaghan3

  • 1Department of Parasitology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.

Insights

This study characterizes the CDPK7 protein from Apicomplexan parasites, revealing its structural features and immunogenic potential. These findings are crucial for developing future vaccines against toxoplasmosis.

Area of Science:

  • Parasitology
  • Biochemistry
  • Bioinformatics

Background:

  • Apicomplexan parasites like *Toxoplasma gondii* utilize calcium-dependent protein kinases (CDPKs) for host cell invasion and egress.
  • CDPKs play diverse roles in parasite biology, making them potential targets for therapeutic intervention.

Purpose of the Study:

  • To predict the basic features and specifications of the CDPK7 protein using bioinformatics tools.
  • To evaluate the antigenicity and allergenicity of the CDPK7 protein.

Main Methods:

  • Bioinformatic analysis using various web servers.
  • Prediction of protein features: amino acid count, molecular weight, aliphatic index, GRAVY score.
  • Secondary structure prediction (alpha-helix, random coils, extended strands) using GOR4 method.
  • Ramachandran plot analysis for stereochemical quality.
  • Antigenicity and allergenicity assessment.

Main Results:

  • CDPK7 protein comprises 2133 amino acid residues with a molecular weight of 219085.79 D.
  • Estimated aliphatic index of 68.78 and a GRAVY score of -0.331.
  • Secondary structure analysis revealed 502 alpha-helices, 1311 random coils, and 320 extended strands.
  • Ramachandran plot indicated over 92% of residues in favored regions, signifying good stereochemical quality.
  • CDPK7 was predicted to be immunogenic and nonallergenic.

Conclusions:

  • The CDPK7 protein possesses distinct structural and physicochemical properties.
  • Its immunogenic and nonallergenic nature suggests potential as a vaccine candidate.
  • This data provides a foundation for further in vivo studies to develop effective toxoplasmosis vaccines.